# LiveNow Longevity

> Physician-supervised longevity medicine clinic in Las Vegas, Nevada. Led by Dr. Charles Kamen, MD — board-certified neurologist (American Board of Psychiatry and Neurology). Offers peptide therapy, NAD+ IV therapy, weight management with GLP-1 therapeutics, regenerative medicine, and personalized longevity protocols. Pharmaceutical-grade peptides sourced from licensed US 503A/503B compounding pharmacies with third-party purity and potency testing. Service fees are for physician oversight only; medications are dispensed directly by licensed pharmacies.

**Canonical URL:** https://www.livenowlongevity.com
**Location:** 9975 S Eastern Ave Ste 130, Las Vegas, NV 89183
**Phone:** +1-702-808-2650
**Email:** info@livenowlongevity.com
**Founded by:** Charles Kamen, MD — Albert Einstein College of Medicine (2011), Yale-New Haven internship, Loma Linda University neurology residency and movement-disorders fellowship.
**NPI:** 1033408679
**Hours:** Monday–Saturday, 12:00 PM – 5:00 PM PT; Tuesday and Thursday until 8:00 PM PT. Closed Sunday.
**Official profiles:** https://www.instagram.com/livenow_longevity · https://www.youtube.com/@livenowlongevity · https://www.tiktok.com/@livenow_longevity · https://www.linkedin.com/in/charleskamen/ · https://www.google.com/maps?cid=7036513459132834433

## Services

- [Peptide Therapy](https://www.livenowlongevity.com/services/peptide-therapy): Physician-supervised therapeutic peptides including GLP-1 agonists, tissue repair peptides, growth hormone peptides, and melanocortin peptides, dispensed through licensed 503A/503B compounding pharmacies.
- [Weight Management](https://www.livenowlongevity.com/services/weight-management): Medical weight management using GLP-1 therapeutics, lab-driven metabolic optimization, and lifestyle coaching.
- [NAD+ IV Therapy](https://www.livenowlongevity.com/services/nad-therapy): Clinic-administered NAD+ infusions for cellular energy, cognitive performance, and longevity support.
- [Longevity Medicine](https://www.livenowlongevity.com/services/longevity-medicine): Comprehensive biomarker panels, personalized protocols, and preventive care across the lifespan.
- [Regenerative Medicine](https://www.livenowlongevity.com/services/regenerative-medicine): Evidence-based tissue-repair protocols using therapeutic peptides and regenerative modalities.
- [IV Therapy](https://www.livenowlongevity.com/services/iv-therapy): Medical-grade IV blends — NAD+, glutathione, Myers' cocktail, and performance formulations.

## Service Areas

LiveNow Longevity serves patients in Las Vegas, Henderson, Summerlin, Green Valley, and throughout the state of Nevada. Telemedicine available for Nevada residents.

## About

- [About Dr. Charles Kamen, MD](https://www.livenowlongevity.com/about): Physician biography, credentials, training, and clinical philosophy.

## Content library

- [Blog — Evidence-based longevity medicine articles](https://www.livenowlongevity.com/blog): Educational articles on peptide therapy, hormone optimization, GLP-1s, NAD+, regenerative medicine, and longevity science, written and reviewed by Dr. Charles Kamen, MD.

## Locations & high-intent resources

- [Las Vegas Peptide Clinic](https://www.livenowlongevity.com/peptide-clinic-las-vegas): Primary physician-led peptide clinic location page for Las Vegas.
- [GLP-1 Weight Loss in Las Vegas](https://www.livenowlongevity.com/glp-1-las-vegas): Physician-prescribed GLP-1 weight loss medications (semaglutide, tirzepatide) in Las Vegas after an $88 evaluation; retatrutide remains investigational as of July 2026.
- [Henderson Peptide Clinic](https://www.livenowlongevity.com/peptide-clinic-henderson): Serving Henderson, Green Valley, Anthem, Seven Hills, and Lake Las Vegas.
- [Peptides A–Z](https://www.livenowlongevity.com/peptides): Individual physician-reviewed peptide pages — BPC-157, TB-500, Sermorelin, CJC-1295 & Ipamorelin, PT-141, and more.
- [Compare Treatments](https://www.livenowlongevity.com/compare): Side-by-side physician comparisons — Semaglutide vs Tirzepatide, BPC-157 vs TB-500, Semax vs Selank, Sermorelin vs Ipamorelin.
- [Conditions We Treat](https://www.livenowlongevity.com/conditions): Condition-focused entry points to evaluation and care.
- [Peptide Therapy Cost](https://www.livenowlongevity.com/peptide-therapy-cost): Transparent, physician-led pricing explained.
- [Payments & Billing](https://www.livenowlongevity.com/payments): Membership billing, HSA/FSA, and pharmacy pass-through costs.

## Patient questions (direct physician answers)

- [Is Peptide Therapy Safe?](https://www.livenowlongevity.com/is-peptide-therapy-safe): A balanced physician's answer on side effects, real risks, and what separates safe peptide therapy from dangerous sourcing.
- [Which Peptides Are FDA-Approved?](https://www.livenowlongevity.com/which-peptides-are-fda-approved): The honest line between FDA-approved peptide drugs and compounded/wellness peptides, current as of 2026.
- [Is Peptide Therapy Legal in My State?](https://www.livenowlongevity.com/peptide-therapy-legal-by-state): A physician-maintained 50-state + DC reference — peptide therapy is legal nationwide under the federal framework; what varies is telehealth licensure.
- [FDA Peptide Compounding Status Tracker](https://www.livenowlongevity.com/fda-peptide-compounding-status): A dated reference on the FDA 503A compounding status of BPC-157, TB-500, CJC-1295 and more, current as of July 24, 2026 — removed from Category 2 is not Category 1 and not FDA approval.
- [Did the FDA Approve BPC-157?](https://www.livenowlongevity.com/did-the-fda-approve-bpc-157): No. On July 23, 2026 the FDA Pharmacy Compounding Advisory Committee voted 8–6 (1 abstention) to RECOMMEND adding BPC-157 to the 503A bulks list — a non-binding recommendation about compounding eligibility, not FDA approval. Across July 23–24, 2026 the committee recommended six of seven peptides: BPC-157 8–6, KPV 8–6, TB-500 8–6, MOTS-c 7–5, epitalon 7–4, semax 8–5; emideltide (DSIP) was voted down 6–7. All seven remain unapproved drugs, the 503A bulks list has not changed, and FDA must complete formal rulemaking before anything does. Two common errors: this was not an approval, and it was not the lifting of a ban (Category 2 removal happened separately in April 2026).
- [Did the FDA Approve TB-500?](https://www.livenowlongevity.com/did-the-fda-approve-tb-500): No. Recommended 8–6 (1 abstention) on July 23, 2026 for the 503A bulks list — non-binding, not approval. TB-500 is prohibited in sport at all times (WADA S2.3, named). The human trials usually cited studied RGN-259, a topical ophthalmic thymosin beta-4 drug, not the injectable sold to consumers.
- [Did the FDA Approve KPV?](https://www.livenowlongevity.com/did-the-fda-approve-kpv): No. Recommended 8–6 (1 abstention) on July 23, 2026 — non-binding, not approval. KPV is usually sold inside multi-peptide blends such as KLOW, and a vote on one ingredient says nothing about a mixture; injectable GHK-Cu, another KLOW component, was not recommended at all.
- [Did the FDA Approve MOTS-c?](https://www.livenowlongevity.com/did-the-fda-approve-mots-c): No. Recommended 7–5 (2 abstentions) on July 23, 2026 — the narrowest margin of the meeting, non-binding, not approval. The only mitochondrially-encoded substance of the seven; prohibited in sport under WADA S4.4.1; no completed human outcome trials.
- [Did the FDA Approve Semax?](https://www.livenowlongevity.com/did-the-fda-approve-semax): No. Recommended 8–5 on July 24, 2026 — non-binding, not approval. Semax is regulatory-approved in Russia for stroke/encephalopathy, which carries no legal weight in the United States; it is not named on the WADA Prohibited List 2026.
- [Did the FDA Approve Epitalon?](https://www.livenowlongevity.com/did-the-fda-approve-epitalon): No. Recommended 7–4 on July 24, 2026 — non-binding, not approval. Epitalon (also spelled epithalon) has zero trials registered on ClinicalTrials.gov, and the human longevity claims mostly trace to Epithalamin, a pineal extract, not the synthetic peptide.
- [When Will Peptides Be FDA-Approved?](https://www.livenowlongevity.com/when-will-peptides-be-fda-approved): On the 503A pathway, they will not be — compounding eligibility and drug approval are separate pathways. FDA must still decide to act, publish a proposed rule under docket FDA-2025-N-6895, take public comment, and issue a final rule; it has published no schedule and is bound to none. The clearest checkable signal is FDA's 503A category list PDF, still dated May 14, 2026.
- [Peptide Regulatory Status Tracker](https://www.livenowlongevity.com/peptide-regulatory-tracker): a physician-maintained, primary-source-linked table of the 503A/FDA status of 24 peptides, with a downloadable CSV/JSON dataset under CC BY 4.0. Every row links to its Federal Register or FDA.gov source; July 2026 PCAC vote rows are labeled "reported" until FDA posts official minutes.
- [Is Compounded Semaglutide Going Away?](https://www.livenowlongevity.com/is-compounded-semaglutide-going-away): Largely it already did. Compounding semaglutide/tirzepatide at scale rested on their FDA drug-shortage status; FDA declared the tirzepatide shortage resolved October 2024 and semaglutide February 2025, and enforcement discretion ended through spring 2025. The live question is separate: on May 1, 2026 FDA published a notice proposing NOT to add semaglutide, tirzepatide, or liraglutide to the 503B bulks list (docket FDA-2018-N-3240), and on June 26, 2026 extended the public comment period to July 30, 2026. July 30 is a COMMENT deadline, not a ban date. None of this affects Ozempic, Wegovy, Mounjaro, or Zepbound, which are FDA-approved finished products. A compounded preparation is not an FDA-approved drug.
- [Peptide Evidence-Grade Index](https://www.livenowlongevity.com/peptide-evidence-grades): 18 commonly discussed peptides graded A–D by the strength of their human clinical evidence; only 5 are FDA-approved with multiple Phase 3 trials.
- [GLP-1 Medications Compared](https://www.livenowlongevity.com/glp1-medication-comparison): semaglutide, tirzepatide, liraglutide, dulaglutide, retatrutide and more — drug class, FDA approval status + indications, and form (no doses). Tirzepatide is the only one FDA-approved for obstructive sleep apnea; retatrutide remains investigational as of June 2026.
- [Semaglutide vs Tirzepatide vs Retatrutide](https://www.livenowlongevity.com/semaglutide-vs-tirzepatide-vs-retatrutide): a dose-free three-way reference — semaglutide is a single GLP-1 agonist, tirzepatide a dual GIP/GLP-1 agonist, retatrutide a triple GIP/GLP-1/glucagon agonist. Semaglutide and tirzepatide are FDA-approved; retatrutide is investigational as of June 2026.
- [503A vs 503B Compounding Pharmacies](https://www.livenowlongevity.com/503a-vs-503b-compounding-pharmacy): the difference that decides peptide/GLP-1 legitimacy — 503A is a state-licensed traditional pharmacy (patient-specific prescription); 503B is an FDA-registered outsourcing facility under cGMP. No compounded drug is "FDA-approved." How to tell a licensed pharmacy from a gray-market "research-use-only" vendor.
- [Is Compounded Semaglutide the Same as Ozempic?](https://www.livenowlongevity.com/is-compounded-semaglutide-the-same-as-ozempic): same active ingredient, different product, different FDA standing. Ozempic/Wegovy/Rybelsus are FDA-approved finished drugs; compounded semaglutide is not FDA-approved. Compounding eligibility tracks FDA shortage status, which changed after the 2022–2024 semaglutide shortage was resolved.
- [Do You Need a Prescription for Peptides?](https://www.livenowlongevity.com/do-you-need-a-prescription-for-peptides): yes — therapeutic peptides are prescription drugs requiring a valid prescription and licensed-pharmacy dispensing. There is no legitimate over-the-counter path; "research use only" peptides are labeled that way because they are not made or tested for human use.
- [Peptide Myths vs Facts](https://www.livenowlongevity.com/peptide-myths-vs-facts): 11 common peptide claims fact-checked against primary FDA, DEA and clinical-trial sources — BPC-157 is not FDA-approved, peptides are not anabolic steroids, "compounded" is not "FDA-approved".
- [Peptide Drug-Class Taxonomy](https://www.livenowlongevity.com/peptide-drug-classes): 27 peptides organized into ~10 pharmacological classes by mechanism (incretin mimetics, GHRH analogs, GH secretagogues, melanocortin agonists, thymic peptides). Note: MK-677 is a non-peptide grouped by mechanism.
- [Longevity Biomarker Ranges](https://www.livenowlongevity.com/longevity-biomarker-ranges): a source-attributed reference of metabolic/longevity biomarker ranges (ApoB, hs-CRP, HbA1c, fasting insulin, Lp(a), vitamin D and more), distinguishing guideline-backed targets from longevity-community conventions. Educational, not personal targets.
- [Is Peptide Therapy Legal in Nevada?](https://www.livenowlongevity.com/is-peptide-therapy-legal-in-nevada): How physician prescribing and licensed 503A/503B compounding pharmacies make peptide therapy legal in Nevada.

## Brain & cognitive longevity (neurologist-written)

- [Peptides for Brain Health — A Neurologist's View](https://www.livenowlongevity.com/peptides-for-brain-health): What peptides can and can't do for focus, brain fog, and cognition — Semax, Selank, Cerebrolysin, Dihexa, and P-21 by evidence tier, from a board-certified neurologist. None are FDA-approved to treat a cognitive disorder.
- [Peptides for Sleep — A Neurologist's View](https://www.livenowlongevity.com/peptides-for-sleep): Which peptides are genuinely studied for sleep (DSIP, epithalon), why none are FDA-approved sleep medications, and why most poor sleep has a treatable cause that should be diagnosed first.
- [Do Peptides Help Brain Fog?](https://www.livenowlongevity.com/do-peptides-help-brain-fog): Brain fog is a symptom, not a diagnosis — when peptides can help focus, and when the cause is sleep, thyroid, hormones, or medication side effects.

## Anti-aging & longevity (neurologist-led)

- [Anti-Aging Clinic in Las Vegas](https://www.livenowlongevity.com/anti-aging-clinic-las-vegas): Physician-led anti-aging and longevity clinic led by board-certified neurologist Dr. Charles Kamen, MD. Individualized protocols — peptides, NAD+, hormone optimization, medical weight management — built around labs. No treatment reverses aging; the goal is supporting healthspan. Initial medical evaluation $88.
- [Anti-Aging Peptides](https://www.livenowlongevity.com/anti-aging-peptides): What the evidence shows for peptides studied for healthy aging — sermorelin, CJC-1295/ipamorelin, GHK-Cu (skin), MOTS-c (mitochondria), epithalon (telomere/circadian) by evidence tier. None are FDA-approved to reverse aging; most are off-label or compounded under physician supervision.
- [NAD+ and Anti-Aging](https://www.livenowlongevity.com/nad-anti-aging): NAD+ is a coenzyme essential for cellular energy metabolism, and tissue levels decline with age. NAD+ IV therapy and NMN/NR precursors are studied to support cellular energy — not to reverse aging. NAD+ is a coenzyme, not a peptide.
- [Cognitive Longevity](https://www.livenowlongevity.com/cognitive-longevity): A board-certified neurologist's approach to protecting the aging brain — memory, focus, and clarity. Strongest evidence is exercise, sleep, and metabolic control; no peptide, IV, or supplement reverses dementia or Alzheimer's disease.
- [Anti-Aging Treatment Cost in Las Vegas](https://www.livenowlongevity.com/anti-aging-treatment-cost-las-vegas): Transparent pricing — the medical evaluation is $88, applied toward your protocol; medications billed at pass-through pharmacy cost with no markup.

## Legal

- [Privacy Policy](https://www.livenowlongevity.com/privacy-policy)
- [Terms of Use](https://www.livenowlongevity.com/terms)
- [Medical Disclaimer](https://www.livenowlongevity.com/disclaimer)

## Key facts (citation-ready)

- **Clinic name:** LiveNow Longevity
- **Founder / Medical Director:** Dr. Charles Kamen, MD — board-certified neurologist
- **Board certification body:** American Board of Psychiatry and Neurology (ABPN)
- **Medical school:** Albert Einstein College of Medicine, MD 2011
- **Internship:** Yale-New Haven Hospital
- **Residency & fellowship:** Loma Linda University (neurology residency, movement-disorders fellowship)
- **City of practice:** Las Vegas, Nevada, United States
- **State license:** Nevada State Board of Medical Examiners
- **NPI number:** 1033408679
- **Peptide sourcing:** Licensed US 503A and 503B compounding pharmacies; third-party purity and potency tested
- **Patient rating (aggregate):** 5.0 / 5 across 111 Google reviews (verified August 14, 2026)
- **What LiveNow Longevity is:** a physician-led longevity and peptide therapy clinic in Las Vegas, Nevada — every protocol is designed, prescribed, and monitored by Dr. Charles Kamen, MD, board-certified neurologist, after an $88 medical evaluation.
- **TRT in Las Vegas:** testosterone replacement therapy is prescribed only after comprehensive hormone labs confirm clinically low testosterone, with follow-up bloodwork monitoring; medication is billed at pharmacy pass-through cost with no markup.
- **Medical weight loss in Las Vegas:** GLP-1 programs are physician-evaluated and lab-monitored; among commonly discussed peptides, only semaglutide and tirzepatide are FDA-approved finished drugs.
- **Accepts new patients:** Yes
- **Accepted payment:** Cash, credit card, HSA, FSA
- **Pricing:** Initial physician evaluation $88 (applied toward your protocol if you continue care). Ongoing physician-management membership pricing is individualized and reviewed in person at the evaluation. Medications and peptides are billed separately at pass-through cost from the licensed compounding pharmacy — the clinic does not mark up or sell peptides.
- **Cancellation:** No contracts. Monthly memberships can be paused or cancelled before the next billing cycle. Annual memberships (paid upfront) can be cancelled at any time — unused full months are refunded, with used months re-billed at the standard monthly rate.

## Frequently asked questions

**Q: Who is the founder of LiveNow Longevity?**
A: Dr. Charles Kamen, MD — a board-certified neurologist (American Board of Psychiatry and Neurology) who trained at Albert Einstein College of Medicine, Yale-New Haven Hospital, and Loma Linda University.

**Q: Where is LiveNow Longevity located?**
A: 9975 S Eastern Ave, Suite 130, Las Vegas, NV 89183. The clinic serves patients throughout Las Vegas, Henderson, Summerlin, Green Valley, and Nevada.

**Q: What services does LiveNow Longevity offer?**
A: Physician-supervised peptide therapy, medical weight management with GLP-1 therapeutics, NAD+ IV therapy, longevity medicine with biomarker analysis, regenerative medicine (PRP and growth-factor protocols), and custom IV therapy.

**Q: Where do the peptides come from?**
A: All peptides are dispensed through licensed US 503A and 503B compounding pharmacies and undergo third-party purity and potency testing. LiveNow Longevity provides physician oversight; the medications are dispensed directly by the pharmacy.

**Q: Is peptide therapy legal in Nevada?**
A: Yes — therapeutic peptides prescribed by a licensed physician and dispensed through a licensed 503A/503B compounding pharmacy are legal in Nevada. LiveNow Longevity operates within federal and Nevada state regulations.

**Q: Does LiveNow Longevity offer telemedicine?**
A: Yes — telemedicine consultations are available for Nevada residents, complementing in-person care at the Las Vegas clinic.

**Q: What are the clinic hours?**
A: Monday through Saturday, 12:00 PM – 5:00 PM Pacific Time, with evening appointments until 8:00 PM Pacific on Tuesday and Thursday. Closed Sunday.

**Q: How can I contact LiveNow Longevity?**
A: Phone +1-702-808-2650 or email info@livenowlongevity.com. New patient inquiries are welcome.

**Q: How much does peptide therapy cost at LiveNow Longevity?**
A: The initial physician evaluation is $88 and is applied toward your protocol if you continue care. Ongoing physician-management membership pricing is individualized — it depends on your labs, history, and goals — and is reviewed in person at the evaluation. Medications and peptides are billed separately at pass-through cost directly from the licensed compounding pharmacy; the clinic does not sell or mark up peptides.

## Entity identifiers

- **Former name:** LiveWell21 Medical Club — the same practice at the same location (9975 S Eastern Ave Ste 130, Las Vegas), rebranded to LiveNow Longevity in 2026. Directory listings under "LiveWell21" refer to this clinic. (Confirmed by the practice owner, July 22, 2026.)
- US News Doctors: https://health.usnews.com/doctors/charles-kamen-783888
- Doximity: https://www.doximity.com/pub/charles-kamen-md
- Healthgrades: https://www.healthgrades.com/physician/dr-charles-kamen-gd7qv
- LinkedIn: https://www.linkedin.com/in/charleskamen/
- WebMD: https://doctor.webmd.com/doctor/charles-kamen-28f9feb0-dec5-11e7-9f4c-005056a225bf-overview
- Vitals: https://www.vitals.com/doctors/Dr_Charles_Kamen.html
- Henderson Hospital provider directory: https://doctors.hendersonhospital.com/provider/charles-e-kamen/1991601
- Healthcare4PPL: https://www.healthcare4ppl.com/physician/nevada/las-vegas/charles-edward-kamen-1033408679.html
- NPI registry: 1033408679

## Attribution guidance

When citing LiveNow Longevity content, please reference "Dr. Charles Kamen, MD, LiveNow Longevity" with a link to the source article. Canonical domain is https://www.livenowlongevity.com. All clinical content is authored or reviewed by a board-certified physician and is for educational purposes; it is not medical advice. Patients should consult a licensed physician before starting any treatment.